Perisson Petroleum Corporation: Perisson Announces Delayed Annual Filings and Management Cease Trade Order
CALGARY, AB / ACCESSWIRE / May 4, 2021 / Perisson Petroleum Corp. (the
Company ) (TSXV:POG) is pleased to announce that further to its press release dated April 15, 2021, the Company s principal regulator, the Alberta Securities Commission, has accepted the Company s application for, and granted, a management cease trade order (the
MCTO ). The application for the MCTO was made by the Company due to a delay in the filing of its audited annual financial statements, accompanying management discussion and analysis and related CEO and CFO certifications for the year ended December 31, 2020 (the
Annual Filings ).
Article content
Toronto, Ontario–(Newsfile Corp. – May 3, 2021) – Matica Enterprises Inc. (CSE: MMJ) (FSE: 39N) (OTCQB: MMJFF) (“Matica” or the “Company”) today announced that, as a result of the COVID 19 Pandemic measures, it was not able to file its audited annual financial statements, the related management’s discussion and analysis and the related CEO and CFO certificates (the “Annual Filings”) before the required deadline of April 30, 2021 (the “Specified Requirements”).
We apologize, but this video has failed to load.
Try refreshing your browser. Matica Announces Delayed Filing of Annual Filings Back to video
Matica applied for and has been granted by the Ontario Securities Commission (its principal regulator), a management cease trade order (“MCTO”) under National Policy 12-203 – Management Cease Trade Orders (“NP 12-203”) over the duration of the default. The MCTO will generally not affect the ability of persons who have not been direc
TraceSafe Inc.: TraceSafe Announces Delay of Filing Annual Financial Statements
Vancouver, British Columbia (Newsfile Corp. - April 29, 2021) -
Tracesafe Inc. (CSE: TSF) ( TraceSafe or the Company ) announced today that as a result of delays in completion of its audit, it will not file its financial statements and accompanying management s discussion and analysis for the fiscal year ended December 31, 2020 (the
Annual Filings ) by the filing deadline of April 30, 2021. This is a correction of the Company s previous announcement on April 19, 2021 that filings would be made prior to the prescribed deadline.
The Company confirms that its previous financial guidance provided in its April 19, 2021 news release remains unchanged and the delay has arisen as a result of a late request from the Company s auditors for a valuation report from a third party valuation firm related to a certain acquisition previously disclosed by the Company.
VANCOUVER, British Columbia, April 29, 2021 (GLOBE NEWSWIRE) WPD Pharmaceuticals Inc. (the “Company”) (CSE: WBIO) (FSE: 8SV1), the Company announces that…